Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.
about
Biomarkers for determining the prognosis in chronic myelogenous leukemiaTyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma.Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin.Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?Pharmacology and pharmacokinetics of imatinib in pediatric patients.
P2860
Q26824660-E6165AA9-78AD-48EC-A3E3-D28B2634E1F8Q30242015-D082CEB8-2295-42C6-942C-92A2976073FEQ34525644-29A6B2DE-C7CD-41FF-8AC6-A1E783FAB86AQ38910072-ADB261FB-3A5A-40FB-993B-BE63201E4DECQ41568738-3D802772-FC0A-4E74-AA73-251ACAF7B608Q43841175-4408E6C5-2B75-4F1F-B2FE-89A34489C1C3Q44027139-17C4E9CA-FF66-4158-ACED-9439EACC0956Q48174042-3792ADE8-1B3A-4565-B2F0-EE89D9900DD3Q48189225-126E21F7-A450-4560-BDD3-AAE7970B5568Q48278939-72C22FED-5821-4621-A009-C67B2F1FE80FQ50094239-FE736DDB-1A2D-4766-AB41-A7012FA15AE6
P2860
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Trough plasma imatinib levels ...... osed chronic myeloid leukemia.
@ast
Trough plasma imatinib levels ...... osed chronic myeloid leukemia.
@en
type
label
Trough plasma imatinib levels ...... osed chronic myeloid leukemia.
@ast
Trough plasma imatinib levels ...... osed chronic myeloid leukemia.
@en
prefLabel
Trough plasma imatinib levels ...... osed chronic myeloid leukemia.
@ast
Trough plasma imatinib levels ...... osed chronic myeloid leukemia.
@en
P2093
P2860
P1433
P1476
Trough plasma imatinib levels ...... nosed chronic myeloid leukemia
@en
P2093
Byung Soo Kim
Chul Soo Kim
Chul Won Jung
Dae Young Zang
Deog Yeon Jo
Dong Hwan Kim
Eun Kyung Park
Hong Ghi Lee
P2860
P304
P356
10.3109/10428194.2011.563885
P577
2011-04-04T00:00:00Z